You have 9 free searches left this month | for more free features.

Small Cell Lung Carcinoma

Showing 1 - 25 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

TRAcking Non-small Cell Lung Cancer Evolution Through Therapy

Not yet recruiting
  • Lung Cancer, Non-small Cell
  • Small Cell Lung Cancer
    • (no location specified)
    Nov 16, 2022

    Metastatic NSCLC (NSCLC), NSCLC Metastatic, NSCLC Stage II Trial in Oldenburg (data collection)

    Recruiting
    • Metastatic Non-small Cell Lung Cancer (NSCLC)
    • +5 more
    • data collection
    • Oldenburg, Germany
      Pius-Hospital
    Jul 20, 2022

    NSCLC Trial in Xinxiang (CCCR-NK92 cells)

    Enrolling by invitation
    • Non-small Cell Lung Cancer
    • CCCR-NK92 cells
    • Xinxiang, Henan, China
      The first Affiliated Hospital of Xinxiang Medical University
    Feb 10, 2022

    Small-cell Lung Cancer, Small Cell Lung Carcinoma Trial in Pittsburgh (Onvansertib)

    Recruiting
    • Small-cell Lung Cancer
    • Small Cell Lung Carcinoma
    • Pittsburgh, Pennsylvania
      UPMC Hillman Cancer Center
    Jul 29, 2022

    Non Small Cell Lung Cancer, NSCLC, Small-cell Lung Cancer Trial in Saint Louis (ADI-PEG 20, Gemcitabine, Docetaxel)

    Not yet recruiting
    • Non Small Cell Lung Cancer
    • +3 more
    • ADI-PEG 20
    • +2 more
    • Saint Louis, Missouri
      Washington University School of Medicine
    Nov 14, 2022

    Proteomics in Small Cell Lung Cancer

    Not yet recruiting
    • Small Cell Lung Cancer
      • (no location specified)
      Nov 14, 2022

      EGFR-Mutated Non-Small-Cell Lung Carcinoma, Small Cell/Neuroendocrine Trial run by the National Cancer Institute (NCI)

      Recruiting
      • EGFR-Mutated Non-Small-Cell Lung Carcinoma
      • Small Cell/Neuroendocrine
      • Bethesda, Maryland
        National Institutes of Health Clinical Center
      Aug 20, 2022

      Stage I Lung Cancer, Stage I NSCLC AJCC v7, Stage IA Non-Small Cell Lung Carcinoma AJCC v7 Trial in Atlanta (drug, procedure,

      Active, not recruiting
      • Stage I Lung Cancer
      • +7 more
      • Fludeoxyglucose F-18
      • +2 more
      • Atlanta, Georgia
        Emory University Hospital/Winship Cancer Institute
      Mar 2, 2022

      NSCLC, Carcinoma, Small Cell Lung, Carcinoma, Thymic Trial run by the National Cancer Institute (NCI) (AZD6244, MK-2206,

      Active, not recruiting
      • Carcinoma, Non-Small-Cell Lung
      • +2 more
      • Bethesda, Maryland
        National Institutes of Health Clinical Center, 9000 Rockville Pi
      Aug 24, 2022

      NSCLC Trial in Melbourne, London (Pembrolizumab, Radiotherapy (SABR))

      Completed
      • Non-small Cell Lung Cancer
      • Melbourne, Victoria, Australia
      • +1 more
      May 23, 2022

      Small-cell Lung Cancer, Small Cell Lung Carcinoma Trial in Saint Louis (Mycophenolate Mofetil, Allopurinol, Irinotecan)

      Not yet recruiting
      • Small-cell Lung Cancer
      • Small Cell Lung Carcinoma
      • Mycophenolate Mofetil
      • +2 more
      • Saint Louis, Missouri
        Washington University School of Medicine
      May 17, 2022

      Small Cell Lung Cancer Trial in Lexington (Rucaparib and Nivolumab)

      Recruiting
      • Small Cell Lung Cancer
      • Rucaparib and Nivolumab
      • Lexington, Kentucky
        Markey Cancer Center, University of Kentucky
      Aug 9, 2021

      Small Cell Lung Cancer Extensive Stage, Large Cell Neuroendocrine Carcinoma of the Lung Trial (LB2102)

      Not yet recruiting
      • Small Cell Lung Cancer Extensive Stage
      • Large Cell Neuroendocrine Carcinoma of the Lung
      • LB2102
      • (no location specified)
      Jan 10, 2023

      NSCLC, EGF-R Positive NSCLC Trial in Shanghai (Furmonertinib)

      Recruiting
      • NSCLC
      • EGF-R Positive Non-Small Cell Lung Cancer
      • Shanghai, Shanghai, China
        Shanghai General Hospital
      Jan 12, 2022

      Small Cell Lung Carcinoma Trial in Goyang-si (IP chemo, IP chemo plus simvastatin)

      Active, not recruiting
      • Small Cell Lung Carcinoma
      • IP chemotherapy
      • IP chemotherapy plus simvastatin
      • Goyang-si, Gyeonggi-do, Korea, Republic of
        National Cancer Center , Korea
      Apr 4, 2022

      Small Cell Lung Cancer, Neuroendocrine Carcinoma Trial (RO7616789, Tocilizumab)

      Not yet recruiting
      • Small Cell Lung Cancer
      • Neuroendocrine Carcinoma
      • (no location specified)
      Nov 9, 2022

      Small Cell Lung Cancer, Platinum-Sensitive Lung Small Cell Carcinoma, Extensive-stage Small-cell Lung Cancer Trial in Bordeaux

      Not yet recruiting
      • Small Cell Lung Cancer
      • +2 more
      • Association of lurbinectedin and durvalumab
      • Association of carboplatin and etoposide
      • Bordeaux, France
        Institut BergoniƩ
      Oct 5, 2022

      Small Cell Carcinoma, Hypercalcaemic Type, Ovarian Cancer Trial in Toronto (Pembrolizumab)

      Enrolling by invitation
      • Small Cell Carcinoma, Hypercalcaemic Type
      • Ovarian Cancer
      • Toronto, Ontario, Canada
        Princess Margaret Cancer Centre
      May 9, 2022

      Small Cell Lung Cancer, Angiogenesis, Chemo Effect Trial (Surufatinib, Irinotecan)

      Not yet recruiting
      • Small Cell Lung Cancer
      • +2 more
      • (no location specified)
      Oct 24, 2022

      Lung Cancer, Small Cell Lung Carcinoma, Non Small Cell Lung Cancer Trial in Chapel Hill (iC9.GD2.CAR.IL-15 T Infusion)

      Not yet recruiting
      • Lung Cancer
      • +2 more
      • iC9.GD2.CAR.IL-15 T Infusion
      • Chapel Hill, North Carolina
        Lineberger Comprehensive Cancer Center
      Nov 16, 2022

      Non-small Cell Lung Carcinoma Trial (BPI-361175)

      Not yet recruiting
      • Non-small Cell Lung Carcinoma
      • (no location specified)
      Jun 8, 2022

      Small-cell Lung Cancer, Extensive-stage Small-cell Lung Cancer, Lung Cancer Trial (Ablative Radiation, Durvalumab, Etoposide)

      Not yet recruiting
      • Small-cell Lung Cancer
      • +2 more
      • Ablative Radiation
      • +3 more
      • (no location specified)
      Mar 11, 2022

      Non-small Cell Lung Carcinoma, Small Cell Lung Carcinoma Trial in Boston, Newton (Contralateral Esophageal Sparing Technique

      Completed
      • Non-small Cell Lung Carcinoma
      • Small Cell Lung Carcinoma
      • Contralateral Esophageal Sparing Technique (CEST)
      • Boston, Massachusetts
      • +1 more
      Dec 8, 2021

      Lung Cancer, Small-cell Lung Cancer Trial in Lebanon (Trilaciclib, Lurbinectedin)

      Not yet recruiting
      • Lung Cancer
      • Small-cell Lung Cancer
      • Lebanon, New Hampshire
        Dartmouth Hitchcock Medical Center
      Oct 12, 2022

      Biology of Young Lung Cancer Study: The YOUNG LUNG Study

      Not yet recruiting
      • Non Small Cell Lung Cancer
      • Small Cell Lung Carcinoma
      • Data and Specimen Collection
      • Boston, Massachusetts
      • +3 more
      Feb 22, 2022